Alanine Aminotransferase as the First Test Parameter for Wilson’s Disease
Open Access
- 29 November 2019
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 7 (X), 1-4
- https://doi.org/10.14218/jcth.2019.00042
Abstract
Background and Aims: The liver is the first organ affected by toxic copper in the classical and severe hepatic forms of Wilson’s disease (WD). Because their associated chronic liver damage is mostly asymptomatic, an intervention using a special test including serum alanine aminotransferase (ALT) activity is needed for detecting WD. Methods: Using the modified international criteria for the diagnosis of WD, 45 patients were selected from the collective databases of our institutions, and 7 infants were reviewed from the literature. Two patients had the severe hepatic form, with normoceruloplasminemia and no mutations in ATP7B. The rapid ALT change during hemolytic anemia was adjusted for a baseline. The diagnostic potential of the ALT test was assessed from the age-dependent natural course of the liver damage of WD. Results: The natural course had three stages. ALTs were still low in some infants younger than 4 years-old. They were high in all children between the ages of 4 and 8 years-old; then, they reduced to low levels in some patients over 9 years of age. The high ALT stage represents chronic active hepatitis, and the subsequent low ALT stage is due to silent cirrhosis. The hepatic copper content is a reliable but invasive test, while urinary copper secretion is an alternative, non-invasive test for copper toxicosis of WD. The serum ceruloplasmin and ATP7B analyses are subtype tests of WD. The response to anti-copper regimens is the final test result. Conclusions: ALT could be the first parameter to test to detect WD in children between the ages of 4 and 8 years.This publication has 27 references indexed in Scilit:
- Phenotype-Genotype Correlation in Wilson Disease in a Large Lebanese Family: Association of c.2299insC with Hepatic and of p. Ala1003Thr with Neurologic PhenotypePLOS ONE, 2014
- Genetically confirmed Wilson disease in a 9-month old boy with elevations of aminotransferasesWorld Journal of Hepatology, 2013
- Progressive Familial Intrahepatic Cholestasis Type 3Clinical Pediatrics, 2012
- Serum 'free' copper in Wilson diseaseQJM: An International Journal of Medicine, 2011
- Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, by S. A. Kinnier Wilson, (From the National Hospital, and the Laboratory of the National Hospital, Queen Square, London) Brain 1912: 34; 295-509.Brain, 2009
- EditorialBrain, 2009
- Influence of hemolysis on routine clinical chemistry testingcclm, 2006
- Molecular diagnosis of Wilson's diseaseThe Lancet, 1997
- Chronic Hepatitis As a First Manifestation of Wilson's DiseaseAnnals of Internal Medicine, 1972
- Deficiency of Ceruloplasmin in Patients with Hepatolenticular Degeneration (Wilson's Disease)Science, 1952